10.11.5What are the diagnostic tests available for detection of toxoplasmosis infection and how do they compare in terms of specificity, sensitivity and cost effectiveness?

StudyRef.PopulationInterventionOutcomesResultsCommentsStudy typeEL
Cubitt et al., 1992474Sera from 1000 pregnant women booking for antenatal care at a London hospitalSerological screening for antibodies to toxoplasmosis with gold standard based on repeat testing resultsComparison of DA, LA and EIAs49/1000 discordant results among all assays and required repeat testing; 9 remained undetermined
EIAs: 0/773 false positives, 2/218 false negatives
LA: 0/218 false negatives, 1/773 false positives
DA: 0/218 false negative, 23/773 false positives
TES3

From: Evidence tables

Cover of Antenatal Care
Antenatal Care: Routine Care for the Healthy Pregnant Woman.
NICE Clinical Guidelines, No. 62.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2008 Mar.
Copyright © 2008, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.